At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains. Supply chain ...

Copeland's Dickson buy adds cloud-native monitoring as the pharma cold chain moves toward continuous visibility to meet ...

AI should not be framed as influencing prescribing; it can close the information-access gap by delivering brand-approved, ...

Explain why commercialization readiness begins much sooner than executives think. Identify early operational ...

Resilience is positioned as an anticipatory capability enabled by visibility, planning maturity, and partnerships, not merely reactive contingency management amid disruption and cost pressure. AI ...

Identify early operational decisions—product handling requirements, product configuration, transportation strategies, temperature management requirements, and supply chain design—that affect ...

The US drug wholesaling industry is stable post-opioid settlement, with focus shifting to fund management and pharmacy benefit managers. The Big Three wholesalers are financially strong, expanding ...

Tempaid expands capability in parcel/last-mile formats, including SpeedyPac and SteadyPac lines, plus in-house R&D, ...

In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity. Welcome to Pharma Pulse, a ...

As patient expectations continue to evolve, brick-and-mortar pharmacy’s path forward lies in combining trusted, face-to-face ...

Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke. There are nine pieces in this issue. Three left me with ...

Most favored nation agreements now encompass 26 manufacturers, signaling rapid normalization of pricing constraints across portfolios and compressing traditional strategic levers. List-price/rebate ...